Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

Discontinuing PJP prophylaxis while on prednisone doses greater than 12.5 mg per day may elevate infection risk among patients with rheumatic diseases.

Topline data were announced from two phase 3 trials evaluating MR-107A-02 for the treatment of moderate to severe acute pain.

A low dose combination hormonal patch was found to be effective for pregnancy prevention based on results from a phase 3 study.

Type 1 diabetes was associated with an increased risk for osteoporotic fracture regardless of femoral neck bone mineral density among men and women. Patients with type 1 diabetes (T1D) are at higher ...

The mortality rate for US children contracting the flu was greater than 2009. HealthDay News — More U.S. children have died from the flu this season than in any year since the 2009 swine flu pandemic, ...

Intracranial GCA appears to be more common than previously thought and is linked to higher rates of stroke and mortality.

Osteoboost, a targeted vibration therapy device, is now available to improve bone strength and bone density in postmenopausal women.

The use of HCQ among patients with SSc appears to be low and is not associated with improvements in hand function or activities of daily living.

Results of the updated systematic review informing the 2024 EULAR recommendations showed that many ARDs are safe to use during pregnancy, lactation, and reproduction.

Individuals with type 2 diabetes or a higher BMI may face a reduced risk of developing GCA, while a history of cardiovascular disease may increase this risk.

Here's a new summary of all the drugs in the pipeline currently being evaluated for the treatments of vasculitis.